This morning's market numbers show the potential of any drug that can treat this virus will change the global dynamic. Most bio stocks are in the red with the exception of Gilead. CYDY is holding steady so I'm more than happy with the stability we have right now. Even the slightest hint of being a contender in treating this virus will make our company a household term. Stay the course, meet the milestones, and the historical results will follow.